247 related articles for article (PubMed ID: 25544376)
1. Differential expression of the multidrug resistance 1 (MDR1) protein in prostate cancer cells is independent from anticancer drug treatment and Y box binding protein 1 (YB-1) activity.
Saupe M; Rauschenberger L; Preuß M; Oswald S; Fussek S; Zimmermann U; Walther R; Knabbe C; Burchardt M; Stope MB
World J Urol; 2015 Oct; 33(10):1481-6. PubMed ID: 25544376
[TBL] [Abstract][Full Text] [Related]
2. Interaction between docetaxel resistance and castration resistance in prostate cancer: implications of Twist1, YB-1, and androgen receptor.
Shiota M; Kashiwagi E; Yokomizo A; Takeuchi A; Dejima T; Song Y; Tatsugami K; Inokuchi J; Uchiumi T; Naito S
Prostate; 2013 Sep; 73(12):1336-44. PubMed ID: 23775496
[TBL] [Abstract][Full Text] [Related]
3. [Connection of intracellular protein YB-1 localization in cell cultures of human tumors with multidrug resistance].
Rybalkina EIu; Stromskaia TP; Ovchinnikov LP; Stavrovskaia AA
Vopr Onkol; 2013; 59(5):623-8. PubMed ID: 24260892
[TBL] [Abstract][Full Text] [Related]
4. Serum exosomal P-glycoprotein is a potential marker to diagnose docetaxel resistance and select a taxoid for patients with prostate cancer.
Kato T; Mizutani K; Kameyama K; Kawakami K; Fujita Y; Nakane K; Kanimoto Y; Ehara H; Ito H; Seishima M; Deguchi T; Ito M
Urol Oncol; 2015 Sep; 33(9):385.e15-20. PubMed ID: 26027763
[TBL] [Abstract][Full Text] [Related]
5. FOXO3a Expression Regulated by ERK Signaling is Inversely Correlated With Y-Box Binding Protein-1 Expression in Prostate Cancer.
Imada K; Shiota M; Kuroiwa K; Sugimoto M; Abe T; Kohashi K; Yokomizo A; Eto M; Naito S; Oda Y
Prostate; 2017 Feb; 77(2):145-153. PubMed ID: 27699813
[TBL] [Abstract][Full Text] [Related]
6. [Effects of changwelqing on nuclear translocation of Y-box binding protein-1 and expression of P-glycoprotein in human colon cancer cell line with drug-resistance induced by vincristine].
Xu JH; Deng WL; Fan ZZ
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2010 Jul; 30(7):743-7. PubMed ID: 20929136
[TBL] [Abstract][Full Text] [Related]
7. [Effect of regulation of Y-box protein 1 by RNA interference on the doxorubicin induced mdr1 gene expression in K562 cells].
Shen HL; Xu WL; Chen QY; Wang FC; Fei X
Zhonghua Xue Ye Xue Za Zhi; 2011 Jun; 32(6):383-7. PubMed ID: 21781495
[TBL] [Abstract][Full Text] [Related]
8. Increased nuclear localization of transcription factor Y-box binding protein 1 accompanied by up-regulation of P-glycoprotein in breast cancer pretreated with paclitaxel.
Fujita T; Ito K; Izumi H; Kimura M; Sano M; Nakagomi H; Maeno K; Hama Y; Shingu K; Tsuchiya S; Kohno K; Fujimori M
Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8837-44. PubMed ID: 16361573
[TBL] [Abstract][Full Text] [Related]
9. Targeting ribosomal S6 kinases/Y-box binding protein-1 signaling improves cellular sensitivity to taxane in prostate cancer.
Shiota M; Itsumi M; Yokomizo A; Takeuchi A; Imada K; Kashiwagi E; Inokuchi J; Tatsugami K; Uchiumi T; Naito S
Prostate; 2014 Jun; 74(8):829-38. PubMed ID: 24729449
[TBL] [Abstract][Full Text] [Related]
10. Y-box binding protein-1 promotes castration-resistant prostate cancer growth via androgen receptor expression.
Shiota M; Takeuchi A; Song Y; Yokomizo A; Kashiwagi E; Uchiumi T; Kuroiwa K; Tatsugami K; Fujimoto N; Oda Y; Naito S
Endocr Relat Cancer; 2011 Aug; 18(4):505-17. PubMed ID: 21652770
[TBL] [Abstract][Full Text] [Related]
11. The transcription factor ZEB1 promotes chemoresistance in prostate cancer cell lines.
Orellana-Serradell O; Herrera D; Castellón EA; Contreras HR
Asian J Androl; 2019; 21(5):460-467. PubMed ID: 30880686
[TBL] [Abstract][Full Text] [Related]
12. Regulation of MDR1 gene expression in multidrug-resistant cancer cells is independent from YB-1.
Kaszubiak A; Kupstat A; Müller U; Hausmann R; Holm PS; Lage H
Biochem Biophys Res Commun; 2007 May; 357(1):295-301. PubMed ID: 17418094
[TBL] [Abstract][Full Text] [Related]
13. The basic and clinical implications of ABC transporters, Y-box-binding protein-1 (YB-1) and angiogenesis-related factors in human malignancies.
Kuwano M; Uchiumi T; Hayakawa H; Ono M; Wada M; Izumi H; Kohno K
Cancer Sci; 2003 Jan; 94(1):9-14. PubMed ID: 12708467
[TBL] [Abstract][Full Text] [Related]
14. Multidrug resistance in prostate cancer.
van Brussel JP; Mickisch GH
Onkologie; 2003 Apr; 26(2):175-81. PubMed ID: 12771527
[TBL] [Abstract][Full Text] [Related]
15. EGFR mediates docetaxel resistance in human castration-resistant prostate cancer through the Akt-dependent expression of ABCB1 (MDR1).
Hour TC; Chung SD; Kang WY; Lin YC; Chuang SJ; Huang AM; Wu WJ; Huang SP; Huang CY; Pu YS
Arch Toxicol; 2015 Apr; 89(4):591-605. PubMed ID: 24888374
[TBL] [Abstract][Full Text] [Related]
16. Direct involvement of the Y-box binding protein YB-1 in genotoxic stress-induced activation of the human multidrug resistance 1 gene.
Ohga T; Uchiumi T; Makino Y; Koike K; Wada M; Kuwano M; Kohno K
J Biol Chem; 1998 Mar; 273(11):5997-6000. PubMed ID: 9497311
[TBL] [Abstract][Full Text] [Related]
17. YB-1 is upregulated during prostate cancer tumor progression and increases P-glycoprotein activity.
Giménez-Bonafé P; Fedoruk MN; Whitmore TG; Akbari M; Ralph JL; Ettinger S; Gleave ME; Nelson CC
Prostate; 2004 May; 59(3):337-49. PubMed ID: 15042610
[TBL] [Abstract][Full Text] [Related]
18. Clusterin is a critical downstream mediator of stress-induced YB-1 transactivation in prostate cancer.
Shiota M; Zoubeidi A; Kumano M; Beraldi E; Naito S; Nelson CC; Sorensen PH; Gleave ME
Mol Cancer Res; 2011 Dec; 9(12):1755-66. PubMed ID: 21987172
[TBL] [Abstract][Full Text] [Related]
19. Expression of multidrug resistance proteins in prostate cancer is related with cell sensitivity to chemotherapeutic drugs.
Sánchez C; Mendoza P; Contreras HR; Vergara J; McCubrey JA; Huidobro C; Castellón EA
Prostate; 2009 Sep; 69(13):1448-59. PubMed ID: 19496068
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of the multidrug-resistant phenotype by targeting YB-1 with a conditionally oncolytic adenovirus: implications for combinatorial treatment regimen with chemotherapeutic agents.
Mantwill K; Köhler-Vargas N; Bernshausen A; Bieler A; Lage H; Kaszubiak A; Surowiak P; Dravits T; Treiber U; Hartung R; Gansbacher B; Holm PS
Cancer Res; 2006 Jul; 66(14):7195-202. PubMed ID: 16849566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
